Bausch Beats Humana’s Effort to Revive Parts of Glumetza Lawsuit

Humana Inc. lost its bid to resurrect a raft of state law claims over “grotesque price hikes” involving the Bausch Health Cos. diabetes drug Glumetza, when a federal judge in San Francisco rejected the insurer’s request to amend its antitrust lawsuit.

Judge William Alsup denied Humana’s motion, reiterating the criticism of the company’s litigation approach that he offered in his December ruling dismissing its 137 state law claims against Bausch, Assertio Therapeutics Inc., and Lupin Ltd. on jurisdictional grounds.

The judge acknowledged that Humana’s amended complaint included information that “appears” to establish its standing to bring the state law ...